Results 81 to 90 of about 1,096 (177)
Introduction Inflammation is emerging as an important risk factor for atherosclerotic cardiovascular disease and has been a recent target for many novel therapeutic agents.
George A Wells +9 more
doaj +1 more source
ABSTRACT Eicosanoids are important vascular regulators, but the phospholipase A2 (PLA2) isoforms supporting their production within the cardiovascular system are not fully understood. To address this, we have studied platelets, endothelial cells, and leukocytes from 2 siblings with a homozygous loss‐of‐function mutation in group IVA cytosolic ...
Nicholas S. Kirkby +11 more
wiley +1 more source
This review first summarizes the complex pathogenesis of atherosclerosis and outlines the limitations of conventional therapies. It then explores innovative nanoparticle drug delivery system (NDDS) developments, detailing their precision targeting strategies, responsiveness to plaque‐specific stimuli, modulation of key pathological processes, and ...
Yunqi Zhang +13 more
wiley +1 more source
Diverse Functions of Secretory Phospholipases A2
Phospholipase A2 enzymes (PLA2s) catalyze the hydrolysis of glycerophospholipids at their sn‐2 position releasing free fatty acids and lysophospholipids. Mammalian PLA2s are classified into several categories of which important groups include secreted PLA2s (sPLA2s) and cytosolic PLA2s (cPLA2s) that are calcium‐dependent for their catalytic activity ...
Preetha Shridas +2 more
wiley +1 more source
sPLA2 isoforms with a similar temporal pattern to sPLA2‐IIA: sPLA2‐IB, IIC, V, X, and XVI sPLA2 isoforms with an inverse temporal pattern to sPLA2‐IIA: sPLA2‐IID and XIIB. Abstract Previous research suggests that group IIA‐secreted phospholipase A2 (sPLA2‐IIA) plays a role in and predicts lethal COVID‐19 disease.
Eric Lu +10 more
wiley +1 more source
Coronary artery disease (CAD) is a multifactorial disorder that results from an excessive inflammatory response. Secretory phospholipase A2‐V (sPLA2‐V) encoded by PLA2G5 gene promotes diverse proinflammatory processes. The aim of the present study was to analyze if PLA2G5 gene polymorphisms are associated with premature CAD. Three PLA2G5 polymorphisms (
Gilberto Vargas-Alarcón +13 more
wiley +1 more source
The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming [PDF]
A global strategy, under the coordination of the World Health Organization, is being unfolded to reduce the impact of snakebite envenoming. One of the pillars of this strategy is to ensure safe and effective treatments.
Abd El-Aziz, Tarek Mohamed +6 more
core +4 more sources
Due to their roles in inflammation, the sPLA2 enzymes are of much medicinal interest. sPLA2 inhibitors have been developed for the treatment of inflammatory and other conditions such as cardiovascular disease, arteriosclerosis and rheumatoid arthritis.
Chantalle Crous +2 more
wiley +1 more source
Identification of distant drug off-targets by direct superposition of binding pocket surfaces. [PDF]
Correctly predicting off-targets for a given molecular structure, which would have the ability to bind a large range of ligands, is both particularly difficult and important if they share no significant sequence or fold similarity with the respective ...
Armen, Roger S, Schumann, Marcel
core +4 more sources
Quercetin derivatives have already shown their anti-inflammatory potential, inhibiting essential enzymes involved in this process. Among diverse pro-inflammatory toxins from snake venoms, phospholipase A2 is one of the most abundant in some species, such
Mariana Novo Belchor +8 more
doaj +1 more source

